Abingdon Health plc (ABDX.L)
Abingdon Health plc engages in the development, manufacture, and distribution of diagnostic devices worldwide. The company offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; PCRD and PCRD FLEX, nucleic acid lateral flow tests used for rapid readouts post isothermal amplification; Abingdon Simply Test, a range of self-tests; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2. It also provides AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. In addition, the company provides contract manufacturing, nucleic acid lateral flow test customization, and lateral flow development and manufacturing services. Further, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
Company Info
Highlights
£11.37M
-£0.01
£3.73M
£2.26M
£266.00K
£5.50 - £11.75
£78.00
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in Abingdon Health plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Abingdon Health plc (ABDX.L) returned -21.29% year-to-date (YTD) and -39.00% over the past 12 months.
ABDX.L
-21.29%
3.74%
-21.29%
-39.00%
N/A
N/A
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of ABDX.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 3.23% | -9.38% | -10.34% | -7.69% | 1.67% | -21.29% | |||||||
| 2024 | -16.82% | -15.30% | 19.35% | 8.11% | 7.50% | -4.65% | 0.00% | -2.44% | -7.50% | -16.22% | -9.68% | 10.71% | -29.55% |
| 2023 | -11.54% | -0.00% | 8.70% | 28.00% | 31.25% | 14.29% | -18.75% | 10.26% | 0.00% | -4.65% | -5.85% | 13.99% | 69.23% |
| 2022 | -49.24% | -32.84% | 6.67% | -4.17% | -4.35% | -0.00% | -9.09% | -37.50% | -0.00% | -1.60% | -26.83% | 44.44% | -80.30% |
| 2021 | 7.94% | -11.76% | -5.56% | -31.76% | 3.45% | -18.33% | -18.37% | 43.75% | -28.70% | 2.44% | -9.52% | -12.90% | -64.98% |
| 2020 | -10.43% | -10.43% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ABDX.L is 12, meaning it’s performing worse than 88% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Abingdon Health plc (ABDX.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Abingdon Health plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Abingdon Health plc was 97.01%, occurring on Dec 16, 2022. The portfolio has not yet recovered.
The current Abingdon Health plc drawdown is 95.14%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.01% | Jan 27, 2021 | 478 | Dec 16, 2022 | — | — | — |
| -11.79% | Dec 18, 2020 | 6 | Dec 29, 2020 | 18 | Jan 25, 2021 | 24 |
Volatility
Volatility Chart
The current Abingdon Health plc volatility is 14.12%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Abingdon Health plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Abingdon Health plc, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how Abingdon Health plc is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ABDX.L relative to other companies in the Diagnostics & Research industry. Currently, ABDX.L has a P/S ratio of 1.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ABDX.L in comparison with other companies in the Diagnostics & Research industry. Currently, ABDX.L has a P/B value of 1.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |